Core Scientific (CORZ) Cash from Investing Activities (2021 - 2026)

Core Scientific (CORZ) has 6 years of Cash from Investing Activities data on file, last reported at -$386.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 334.36% year-over-year to -$386.7 million; the trailing twelve-month figure through Mar 2026 stood at -$1.0 billion (down 582.08% YoY), and the FY2025 full-year result was -$740.8 million, down 678.16% from the prior year.
• Cash from Investing Activities declined to -$386.7 million in Q1 2026, from -$277.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2023 to a low of -$386.7 million in Q1 2026.
• A 5-year average of -$106.8 million and a median of -$32.0 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 101.69% in 2023 and slumped 3656.53% in 2025, its largest moves.
• Tracing CORZ's Cash from Investing Activities over 5 years: stood at -$139.5 million in 2022, then surged by 101.69% to $2.4 million in 2023, then plunged by 1320.25% to -$28.8 million in 2024, then plunged by 864.54% to -$277.8 million in 2025, then plunged by 39.2% to -$386.7 million in 2026.
• Business Quant data shows CORZ's Cash from Investing Activities at -$386.7 million in Q1 2026, -$277.8 million in Q4 2025, and -$254.4 million in Q3 2025.